Heart News – American Heart Association
- Stroke survivors less likely than cancer survivors to have quit smoking, says new study November 17, 2021Research Highlights: Almost 40% of stroke survivors who smoked cigarettes before their stroke continue to smoke, a rate that hasn’t decreased in recent decades, according to a new study analyzing national survey data. Stroke survivors with a history ...
- Fatal heart attack or stroke could be first sign of CVD in some smokers November 17, 2021Research Highlights: Years of research have linked cigarette smoking to premature illness and death from multiple conditions including CVD. However, a new study found that dying of a heart attack or stroke may often be the first sign of CVD in some ...
- Long-term, low-dose aspirin did not affect risk of dementia in adults with type 2 diabetes November 15, 2021Research Highlights: Daily low-dose aspirin taken for an average of seven years did not affect the risk of dementia in adults with type 2 diabetes. The aspirin regimen was neither protective nor harmful regarding dementia risk. A heart attack or ...
- Oral PCSK9 inhibitor found to be safe, effective to lower cholesterol, in first human trial November 15, 2021Research Highlights: Two studies report the safety and effectiveness of MK-0616, a new cholesterol-lowering medicine in a class of drugs called PCSK9 inhibitors. MK-0616 is taken by mouth, as opposed to injection like currently available PCSK9 ...
- Prescription omega-3 pill didn’t affect outcome for non-hospitalized adults with COVID-19 November 15, 2021Research Highlights: Adults with COVID-19 infection who were not hospitalized received a prescription strength, purified omega-3 fatty acid to determine if it might reduce their chance of hospitalization or death. The purified omega-3 fatty acid, ...
- Stem cell therapy for heart failure reduced major CV events and death, not hospitalization November 14, 2021Research Highlights: Adults with chronic, class II or III heart failure with reduced ejection fraction (HFrEF), as defined by the New York Heart Association criteria, who were treated with stem cells experienced a 65% reduction in non-fatal heart ...
- Adults with acute heart failure benefit when treated with a type 2 diabetes medication November 14, 2021Research Highlights: When treated with empagliflozin, adults hospitalized for acute heart failure were 36% more likely to have a clinical benefit, such as a reduction in all-cause mortality, reduction in heart failure events, or an improvement in ...
- Heart failure symptoms improved with a type 2 diabetes medicine in fully remote trial November 14, 2021Research Highlights: Adults with heart failure who took canagliflozin, a medication originally developed to treat type 2 diabetes, reported improvements in their heart failure symptoms whether or not they also had type 2 diabetes. Symptom and quality ...
- Monitoring for individual triggers may reduce episodes of atrial fibrillation November 14, 2021Research Highlights: Personalized testing may help identify triggers for irregular heart rhythms and reduce their frequency in people with atrial fibrillation. Alcohol consumption was linked to having an atrial fibrillation episode. Caffeine did not...
- Novel algorithm on wearable devices can detect irregular heartbeat, may prompt early care November 14, 2021Research Highlights: A novel software algorithm developed for wearable devices, such as smartwatches and fitness trackers, was able to detect irregular heart rhythms. Analysis of heartbeat data for nearly half a million wearable-device users found ...